Two Down, Two To Go: Cephalon Settles With Ranbaxy Over Provigil Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
Nearly two weeks after settling with Teva, Cephalon has reached a settlement with Ranbaxy that is identical to Teva's deal for generic modafinil.
You may also be interested in...
Mylan Settles With Cephalon Over Provigil Generics
Cephalon has reached a settlement with the third of four companies involved in a patent litigation suit over Cephalon's sleep disorder treatment Provigil (modafinil), the company announced Jan. 10
Mylan Settles With Cephalon Over Provigil Generics
Cephalon has reached a settlement with the third of four companies involved in a patent litigation suit over Cephalon's sleep disorder treatment Provigil (modafinil), the company announced Jan. 10
Teva Can Market Generic Provigil Three Years Before Patent Expiration
Under a settlement with Cephalon, Teva’s modafinil can enter the market in 2011 or 2012, depending on a potential pediatric extension.